Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
Company announcement No. 40 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
China's pharma contractors rally on pushback to US supply chain pressure
China's pharmaceutical contractors are showing financial resilience in the face of Washington's push to curb reliance on Chinese supply chains. Analysts said investors were bullish because the US government's recent measures to curb Beijing's rise…
XPH vs PJP: Which Pharma ETF Offers Better Value
Invesco Pharmaceuticals ETF (PJP +0.59%) provides a concentrated, low-volatility approach to drug manufacturers, while the State Street SPDR S&P Pharmaceuticals ETF (XPH -0.87%) offers broader sector exposure at a significantly lower annual cost.
Sun Pharma gets favourable verdict in antitrust-litigation in U.S.
Sun Pharmaceutical Industries on Monday (August 17, 2026) said an appellate court in the United States has passed a judgment in favour of the company and its subsidiaries in the antitrust litigation, in the U.S., relating to a 2008 patent…
Challenge and opportunity in Ireland's regulatory pharma space
Viatris' Suzanne Keating discusses the changing face of pharma frameworks in Ireland and offers advice for young professionals “After finishing my university degree in chemistry in the 1990s, employment opportunities in Ireland were few and…
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Sun Pharmaceutical Industries Ltd. said Monday that a U.S. appellate court affirmed a summary judgment in its favor in an antitrust lawsuit involving a 2008 patent litigation settlement with Pfizer. The case centered on allegations that the…
Pharma companies seek to block state expansion of discount drug program
(The Center Square) – Multiple drug makers in Illinois are challenging a state law that expands the scope of a federal program under Medicare, arguing Illinois doesn't have the authority to make changes to the program. The federal 340B…
USFDA closes inspection of Aurolife Pharma's facility in the US
The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for Raleigh Plant, North Carolina, USA, owned by Aurolife Pharma LLC, a wholly owned arm of Aurobindo Pharma for manufacturing Inhalers…
TDs call on pharma company to work with HSE to give access to life-changing drug Skyclarys
FINE GAEL MEMBERS today met with the manufacturers of Skyclarys, a disease-modifying drug for the rare disease Friedreich's Ataxia. Pressure has been mounting on government leaders to intervene and reverse a HSE decision recommending against…
Nifty, Sensex Decline: Crude Oil Prices, Geopolitical Tensions Impact Indian Markets
Indian benchmark indices, Nifty and Sensex, extended their losing streak for a fifth consecutive session, with rising crude oil prices and ongoing geopolitical tensions in West Asia weighing heavily on investor sentiment. The Sensex declined by…
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript
Monday, Aug. 10, 2026 at 5:00 p.m. ET President and CEO - Josh Riggs Chief Science Officer - Ekke Schutz CFO - Andrea James Investor Relations - Gabrielle Woody Net Revenue -- $239,000 for the second quarter, primarily generated from laboratory…
Nifty falls for 5th day
Benchmark indices Sensex and Nifty ended lower on Monday amid rising crude oil prices and persistent geopolitical tensions in West Asia. The 30-share BSE Sensex declined 281.09 points, or 0.36 per cent, to settle at 77,728.16. During the day, it…
Report: Nestlé could lose control of five Russian subsidiaries
According to the Russian newspaper Kommersant, such a measure could be a first step towards a subsequent change of ownership. The Russian government plans to reportedly examine the request by the end of the year. KS Logistika justifies the move…
Sandoz expands biosimilars business with Chinese biotech deal
The deal covers the development and commercialisation of up to ten so-called biosimilars. The agreement provides for payments totalling up to $322 million (CHF260 million), subject to the achievement of certain development and commercialisation…
Eli Lilly and J&J bounce on new data, as software stocks give up last week's gains
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks are lower to start the week. On one hand, AI component trade…
Receive a Daily briefing on Pharma Industry News
Get Started